Xolair, which blocks the allergic triggers behind 80 per cent of attacks, has been approved for NHS use by the National Institute for Health and Clinical Excellence. Trials have shown the drug can halve the risks of asthma attacks and experts have hailed it a ‘wonder treatment’.
It is the first asthma injection that has been genetically engineered to block IgE – the immunoglobulin responsible for the allergic process which can lead to attacks. The new drug stops the body overreacting to inhaled allergic particles such as tree and grass pollens, cat fur and house-dust mites. Fortnightly or monthly injections have been shown to cut the risk of attacks in those with severe asthma by 55 per cent and reduce hospital admissions by half.
There are 5 million people in Britain with asthma, costing the economy and health service around £8 billion a year. The condition kills more than 1,400 people annually and a further 69,000 are put in hospital, in many cases for weeks.
Professor Britton comments: “Xolair is a breakthrough, the most important advance in asthma treatment for a decade. We can now prescribe Xolair for those severe allergic asthmatics, who are in and out of hospital with significant exacerbations. Our experience with the drug has shown that it has a dramatic effect on the quality of life for this group of unfortunate patients.”
Media enquiries: Peter La, Press Office at the University of Surrey, Tel: 01483 689191 or E-mail: firstname.lastname@example.org
Stuart Miller | alfa
How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine
Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center
On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.
We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...
What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...
For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.
Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...
At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.
No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...
Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.
Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
19.01.2018 | Materials Sciences
19.01.2018 | Health and Medicine
19.01.2018 | Physics and Astronomy